Facebook Twitter RSS Feed

You are here

Coronary Intervention & Surgery

 - lower arrow

Risk of ischemic stroke within one year of acute MI dropped by 20 percent over a 10-year span in the general Swedish population in a study published online Sept. 18 in Stroke.

 - patient bedside manner

When treated for ischemic left ventricular dysfunction, patients who underwent CABG reported better quality-of-life compared with guideline therapy patients at different time points throughout follow-up of nearly five years. The CABG group also had lower depression scores.

 - heart, cardiology, cardiac

Drug-eluting balloons rather than drug-eluting stents may have a place in certain clinical scenarios, cardiologists said Sept. 14 during a press conference at the Transcatheter Cardiovascular Therapeutics scientific session.

 - Neon Heart

Six weeks of triple therapy to provide anticoagulation to patients treated with drug-eluting stents was not superior to six months, according to results of the ISAR-TRIPLE trial presented Sept. 15 at the Transcatheter Cardiovascular Therapeutics scientific session. Panelists suggested sample size was a problem.

 - Stent

Fractional flow reserve-guided side branch lesion stenting holds promise of fewer stents placed and more years between retreatment of stenosis, according to findings presented Sept. 14 at the Transcatheter Cardiovascular Therapeutics (TCT) conference.


More Stories

Hello? Operator? Cardiologists’ communication styles may confuse PCI patients

Joint PCI decision-making may be a best practice, but it appears physicians aren’t encouraging it through their communication styles, according to a paper published online Aug. 25 in JAMA: Internal Medicine.

Meta-analysis gives clarity to bivalirudin’s risk-benefit profile

Compared with heparin, bivalirudin increases the risk of major adverse cardiac events but reduces the risk of bleeding to varying degrees in patients undergoing PCI, a meta-analysis published in the Aug. 16 issue of The Lancet concluded.

High on high-dose aspirin: Bleeding risk influences dosing only slightly

Aspirin dosing patterns after MI seem to favor high doses, regardless of bleeding risks, according to a study published online Aug. 12 in Circulation: Cardiovascular Quality & Outcomes.

Silent & deadly: Cardiac events occur in CAD patients without ischemic, angina symptoms

While coronary artery disease (CAD) patients with both ischemia and angina proved to have higher risks for mortality, 58.2 percent of patients without symptoms died of cardiovascular- or MI-related causes, according to a study published online Aug. 11 in JAMA: Internal Medicine.

Use of quality measures prevents kidney injuries in 1 in 5 PCI patients

Lowering the amount of contrast used and encouraging more oral hydration before and after a PCI procedure reduced contrast-induced acute kidney injury by 21 percent, according to a study published online July 29 in Circulation: Cardiovascular Quality and Outcomes

Timely care for off-hours STEMI still lags in hospitals

Initiatives to provide timely treatment for patients with acute MI overall appear to making an impact but hospitals still have room to improve in their care of patients who present off-hours, an analysis published online July 29 in Circulation: Cardiovascular Quality and Outcomes suggests.

Hybrid coronary revascularization fails to catch on in U.S.

Physicians in the U.S. who treat patients with multivessel coronary disease rarely turn to a hybrid approach for therapy. Over a two-year period, only 0.48 percent of CABG procedures included hybrid coronary revascularization (HCR), reported a study published online July 23 in Circulation.

FDA approves Rebel bare-metal stent

The FDA approved Boston Scientific’s Rebel stent system for treating patients with coronary artery disease. The bare-metal stent consists of a platinum chromium alloy and uses the same design as the company’s Promus Premier stent.

Low-dose heparin in radial PCI rivals bivalirudin at a fraction of its cost

Findings published July 5 in Lancet show low-dose heparin alone to be at least as effective and safe as bivalirudin alone when used in radial PCI in acute MI patients presenting with STEMI, if not more so.

At 2 years, zotarolimus-eluting stents safe, effective in patients with diabetes

Resolute zotarolimus-eluting stents were found to be as safe and effective after two years in small vessels and in patients with diabetes as those with larger diameters or patients without diabetes. In diabetic patients, outcomes were not significantly different between larger and smaller vessel diameters.

Everolimus-eluting stents safe, effective in complex patients at 1 year

In patients with small-vessel coronary artery disease, stenting creates a special set of concerns for providers. A study with XIENCE V everolimus-eluting stents has demonstrated that they are safe and effective in patients with small-vessel disease at one-year follow-up.

Some prasugrel prescribing runs counter to labeling

Prescribing patterns for the anticoagulant prasugrel suggest that there is ample room for improvement.

PCI volume-outcome link holds but threshold is unclear

Volume appears to be key in quality outcomes for PCI, however, the threshold number a provider must perform per year to stay in top form remains elusive, a study published June 17 in Circulation: Cardiovascular Quality and Outcomes stated.

Patient radiation dose drops 61% with imaging changes

Interventional cardiologists reduced the radiation dose in patients with congenital heart disease by 61 percent using a combination of practice and technical changes, according to a study published online June 20 in Catheterization and Cardiovascular Interventions. Most pediatric and adult patients benefited from the revised protocol.

Left radial PCI reduces operators’ radiation exposure by half

Radiation exposure to the operator was nearly half when performing PCI by a left radial approach rather than right, according to a study published online June 18 in the Journal of the American College of Cardiology: Cardiovascular Interventions

Angiography as good as FFR & IVUS for post-PCI long-term survival

While fractional flow reserve (FFR) and intravascular ultrasound (IVUS) may reduce the need for repeat revascularization, they apparently don’t make a dent in long-term mortality compared with angiography-guided PCI. But FFR may help reduce stent use, according to results published online June 23 in JAMA Internal Medicine.

Preoperative beta-blocker use may not help with CABG

The latest study to examine the preoperative use of beta-blockers in CABG found no mortality benefit combined with an uptick in postoperative atrial fibrillation. Still, it probably is not time to take an eraser to related quality metrics or guidelines. 

A break for CABG? Readmissions measure uses clinical data

With penalties for higher-than-expected 30-day readmissions for CABG on the horizon, concerns about how hospitals will be measured have been growing. A method that linked clinical data to administrative data may provide an answer.

Increasing radial PCI use even slightly may lower bleeding rates

Hospitals that readily embraced transradial PCI over a three-year period were more likely to see reduced bleeding rates, an analysis of CathPCI data showed. But even facilities that had modest increases in radial PCI use achieved lower access site and overall bleeding rates.

Off-pump CABG shows short- but not long-term kidney benefits

Patients who underwent off-pump CABG surgery were less likely than on-pump patients to experience postoperative acute kidney injury, based on an analysis of CORONARY data published in the June 4 issue of JAMA. But kidney function remained similar between the groups at one year.